Deciphera Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:D05 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Feb 24	Sell€32,863	Jama Pitman	Individual	2,267	€14.50
16 Feb 24	Sell€32,863	Daniel Martin	Individual	2,267	€14.50
16 Feb 24	Sell€43,634	Thomas Kelly	Individual	3,010	€14.50
16 Feb 24	Sell€37,908	Matthew Sherman	Individual	2,615	€14.50
16 Jan 24	Sell€21,572	Daniel Martin	Individual	1,624	€13.28
16 Jan 24	Sell€32,345	Thomas Kelly	Individual	2,435	€13.28
16 Jan 24	Sell€21,572	Jama Pitman	Individual	1,624	€13.28
16 Jan 24	Sell€32,345	Matthew Sherman	Individual	2,435	€13.28
13 Dec 23	Sell€39,764	Matthew Sherman	Individual	2,792	€14.24
13 Dec 23	Sell€24,596	Daniel Martin	Individual	1,727	€14.24
13 Dec 23	Sell€39,764	Thomas Kelly	Individual	2,792	€14.24
13 Dec 23	Sell€23,671	Jama Pitman	Individual	1,662	€14.24
13 Dec 23	Sell€436,724	Steven Hoerter	Individual	30,664	€14.24
30 Nov 23	Sell€205,161	Daniel Martin	Individual	17,801	€11.53
30 Oct 23	Sell€244,348	Steven Hoerter	Individual	21,573	€11.33
30 Oct 23	Sell€26,731	Matthew Sherman	Individual	2,360	€11.33
30 Oct 23	Sell€26,232	Thomas Kelly	Individual	2,316	€11.33
30 Oct 23	Sell€15,937	Daniel Martin	Individual	1,407	€11.33
30 Oct 23	Sell€15,937	Jama Pitman	Individual	1,407	€11.33
02 Oct 23	Sell€35,495	Matthew Sherman	Individual	2,942	€12.07
16 Jun 23	Sell€21,819	Daniel Flynn	Individual	1,655	€13.18
16 Jun 23	Sell€16,321	Daniel Martin	Individual	1,238	€13.18
16 Jun 23	Sell€21,819	Thomas Kelly	Individual	1,655	€13.18
16 Jun 23	Sell€21,819	Matthew Sherman	Individual	1,655	€13.18
16 Jun 23	Sell€16,321	Jama Pitman	Individual	1,238	€13.18
08 Jun 23	Buy€128,846	Frank Friedman	Individual	10,000	€12.88
10 May 23	Buy€138,851	Dennis Walsh	Individual	11,000	€12.62

Insider Trading Volume

Insider Buying: D05 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of D05?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	8,476	0.0103%
Individual Insiders	615,193	0.744%
Hedge Funds	15,789,564	19.1%
VC/PE Firms	23,107,844	28%
Institutions	43,145,701	52.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.7%.

Top Shareholders

Top 25 shareholders own 85.96% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
28.1%	Brightstar Associates, LLC	23,107,844	€547.2m	0.21%	no data
7.27%	BlackRock, Inc.	5,976,266	€141.5m	9.68%	no data
7.04%	Deerfield Management Company, L.P. Series C	5,788,024	€137.1m	-16.1%	1.71%
6.32%	Armistice Capital LLC	5,200,000	€123.1m	12.8%	2.0%
5.84%	Redmile Group, LLC	4,801,540	€113.7m	7.29%	2.99%
5.35%	The Vanguard Group, Inc.	4,401,636	€104.2m	0.76%	no data
3%	State Street Global Advisors, Inc.	2,470,813	€58.5m	6.91%	no data
2.55%	Morgan Stanley, Investment Banking and Brokerage Investments	2,097,025	€49.7m	60.1%	no data
2.25%	Polar Capital Holdings Plc	1,850,000	€43.8m	5.71%	0.12%
2.21%	Goldman Sachs Group, Investment Banking and Securities Investments	1,817,391	€43.0m	27.3%	0.01%
1.9%	Dimensional Fund Advisors LP	1,561,654	€37.0m	6.29%	no data
1.72%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	1,410,239	€33.4m	7.39%	0.01%
1.49%	Geode Capital Management, LLC	1,221,308	€28.9m	7.45%	no data
1.46%	Emerald Advisers, LLC	1,197,526	€28.4m	0%	0.42%
1.42%	Braidwell LP	1,169,490	€27.7m	-65%	1.3%
1.24%	Frazier Life Sciences Management, LP	1,021,800	€24.2m	176%	0.71%
1.12%	Jefferies Financial Group Inc.,Asset Management Arm	917,515	€21.7m	24.2%	0.26%
0.98%	Assenagon Asset Management S.A.	809,923	€19.2m	0%	0.03%
0.79%	Millennium Management LLC	652,254	€15.4m	84.2%	0.01%
0.7%	New Leaf Venture Partners, LLC	576,975	€13.7m	-52.3%	8.73%
0.68%	Parkman Healthcare Partners LLC	561,025	€13.3m	-6.09%	1.14%
0.64%	UBS Asset Management AG	526,367	€12.5m	14.1%	no data
0.64%	Northern Trust Global Investments	525,503	€12.4m	0.96%	no data
0.63%	Charles Schwab Investment Management, Inc.	515,301	€12.2m	0%	no data
0.61%	Medical Strategy GmbH, Asset Management Arm	504,500	€11.9m	0%	0.45%